Inception Sciences is the platform on development of medicines. The company is created in 2011 with the assistance of Versant Ventures.
Inception Sciences is also engaged in creation of the new companies in partnership with the leading scientists and the large biopharmaceutical companies.
History
2018: Roche buys the program of RS Inception 5
On April 5, 2018 it became known that the Swiss pharmaceutical company Roche (Roche) signed the agreement on acquisition of the program of regenerative therapy of the multiple sclerosis (MS) of Inception 5 at the platform on development of Inception Sciences medicines. Financial terms of transaction are not disclosed, just as also specific purposes which are supposed to be reached using the Inception 5 program do not reveal. Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |